If p53 can't do it, ask p73

被引:0
作者
Lain, Sonia [1 ,2 ]
机构
[1] Univ Dundee, Ninewells Hosp, Dept Surg & Mol Oncol, Dundee, Scotland
[2] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:3290 / 3291
页数:2
相关论文
共 12 条
[1]   Targeted rescue of a destabilized mutant of p53 by an in silico screened drug [J].
Boeckler, Frank M. ;
Joerger, Andreas C. ;
Jaggi, Gaurav ;
Rutherford, Trevor J. ;
Veprintsev, Dmitry B. ;
Fersht, Alan R. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (30) :10360-10365
[2]   Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancy [J].
Bossi, Gianluca ;
Marampon, Francesco ;
Maor-Aloni, Revital ;
Zani, Bianca ;
Rotter, Varda ;
Oren, Moshe ;
Strano, Sabrina ;
Blandino, Giovanni ;
Sacchi, Ada .
CELL CYCLE, 2008, 7 (12) :1870-1879
[3]   Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo [J].
Bottger, A ;
Bottger, V ;
Sparks, A ;
Liu, WL ;
Howard, SF ;
Lane, DP .
CURRENT BIOLOGY, 1997, 7 (11) :860-869
[4]   A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain [J].
Gaiddon, C ;
Lokshin, M ;
Ahn, J ;
Zhang, T ;
Prives, C .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (05) :1874-1887
[5]   Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors [J].
Issaeva, N ;
Bozko, P ;
Enge, M ;
Protopopova, M ;
Verhoef, LGGC ;
Masucci, M ;
Pramanik, A ;
Selivanova, G .
NATURE MEDICINE, 2004, 10 (12) :1321-1328
[6]   Structural basis for understanding oncogenic p53 mutations and designing rescue drugs [J].
Joerger, Andreas C. ;
Ang, Hwee Ching ;
Fersht, Alan R. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (41) :15056-15061
[7]   Reactivation of mutant p53: molecular mechanisms and therapeutic potential [J].
Selivanova, G. ;
Wiman, K. G. .
ONCOGENE, 2007, 26 (15) :2243-2254
[8]   Targeting the MDM2-p53 interaction for cancer therapy [J].
Shangary, Sanjeev ;
Wang, Shaomeng .
CLINICAL CANCER RESEARCH, 2008, 14 (17) :5318-5324
[9]   Physical and functional interaction between p53 mutants and different isoforms of p73 [J].
Strano, S ;
Munarriz, E ;
Rossi, M ;
Cristofanelli, B ;
Shaul, Y ;
Castagnoli, L ;
Levine, AJ ;
Sacchi, A ;
Cesareni, G ;
Oren, M ;
Blandino, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (38) :29503-29512
[10]   In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 [J].
Vassilev, LT ;
Vu, BT ;
Graves, B ;
Carvajal, D ;
Podlaski, F ;
Filipovic, Z ;
Kong, N ;
Kammlott, U ;
Lukacs, C ;
Klein, C ;
Fotouhi, N ;
Liu, EA .
SCIENCE, 2004, 303 (5659) :844-848